Posttransfusion hepatitis in acute myelogenous leukemia. Effect on survival
- 17 October 1980
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 244 (16) , 1806-1807
- https://doi.org/10.1001/jama.244.16.1806
Abstract
The clinical outcomes of 47 patients with acute myelogenous leukemia who entered an intensive chemoimmunotherapy treatment protocol between Jan. 1975 and July 1978 were retrospectively evaluated. Remission duration and survival were substantially longer in patients in whom hepatitis developed.This publication has 1 reference indexed in Scilit:
- Beneficial Effects of Hepatitis in Patients with Acute Myelogenous LeukemiaAnnals of Internal Medicine, 1979